Member Info for PJT12

Sorry, H2! Oops!

Yuyus, no offence but what is the point of speculating on something that we have no precedent to speculate against. Let's not invite further deadlines which could be seen as speculative ammo for potential derampers. Like the company has said, 2Q.

Glad I wasn't tempted to try and trade after yesterday.

I was reading a book about zen meditation the other day and it talked about the difficulty in keeping your mind open to each moment (childlike discovery) in the face of habitual familiarity (Boredom, sitting there, day-in, day-out). In short, the difficulties of avoiding becoming blase. Some have said that yesterday's RNS was a damp squib from the SP perspective and that is true. However, much of this is down to some investors becoming blase about what in ordinary circumstances would be deemed exceptional individual 'peer reviews' in their own right. The problem is that Parsortix is resulting in so many exceptional reviews that these have just become "the norm". New contracts and lab accreditation after FDA approval will provide the "surprise" elements needed to boot up the SP imo.

I am no longer invested here but I still wish the many followers well. I only moved because I preferred another opportunity elsewhere but I still follow AVCT and the various commentators closely. Amongst them is a guy on Twitter, BigBiteNow, who, to my way of thinking, has to date demonstrated himself to be an excellent, unbiased, well-researched and honest Tweeter. Whilst many on here and Twitter come across as either 'for' or 'against', rampers or derampers - with no in between - BigByteNow (Unlike some other high profile pundits) today proved himself to be willing to criticise Avacta very fairly where he feels it is merited, despite being a large LTH. Total respect to him. Those who are still unaware of his Twitter feed, you might want to visit his page, an oasis amongst all the cr@p that is written about this and many other shares.

And, no, this isn't his Mum writing.

Never mind The Book. If there was an Avacta theme song then Johnny Logan would probably be singing it.

We'll get there eventually.

You are probably across this already but just in case...............

http://blog.labroots.com/cytiva-to-host-virtual-open-day-accelerating-diagnostic-test-development/#:~:text=Registration%20is%20now%20open%20for%20Cytiva%E2%80%99s%20Diagnostics%20virtual,to%20commercialization%20faster%2C%20with%20a%20better%20diagnostic%20test.

...........in my opinion.

Paolo Dal Pino, CEO
Eyal Shefer, CFO

Don't forget their names or make the mistake of trusting them to look after your interests again in future.

I'm not even invested here anymore but the Telit BoD should hang their heads in shame. Pathetic individuals. We cannot blame DBAY for taking advantage of what are a bunch of jellyfish from what I've seen of the events here. Sorry but the latter are not fit to run any company.

I don't believe there's any price manipulation here. My gut feeling is that it is edging up to 150 as the FDA decision launch price. That said, it's a guess like most others.

Yes, my apologies.

Apologies. Just delved further. Lesson noted: Don't expect LSE to update the fundamentals page on time and delve further! I'm in.

Would it be fair to say that this company is on the edge of commercialisation but people such as myself who are looking to buy-in are waiting for the likely fundraise? Once that is in place then the SP is likely to rise fairly quickly to where it should be.

Maybe I'm getting delusions of adequacy but I'm wondering if my email content prompted them to leak their response deliberately to cover the unjust blame that was falling on the MHRA?

Maybe I've just been watching too many reruns of Yes Minister.

My mispelling of services

It is: MHRA Customer Service Centre

Having written to that department at 0958 this morning and been referred to the following reply, Sticky, if you are reading this, what CSC reference number did it include. That will obviously mean nothing on to those on here but it might confirm your docs authenticity:

Please can you tell me why you are taking so long to approve the Avacta Lateral Flow Test? I ask because various theories on it's obstruction within your department and at Porton Down are starting gain traction on the company's share chat page at the London South East website. This especially centres on Cumming's testimony yesterday.

Regards

REPLY

Dear Enquirer,



Thank you for your email.



We have reviewed your enquiry and this has been passed on to our Devices experts.



Should you have any other questions or requests please feel free to call us on 0203 080 6000 or email at info@mhra.gov.uk



Our opening hours are Mon – Fri 9am to 5pm (excluding UK Public Holidays)

Kind regards



Ella
Customer Servicrs

Templar, I've read some petty stupid posts on here but your latest seriously takes the biscuit. If you think that the CCP will be happy just 'taking us out' on the economic front then you need to do some serious political research. Come back to me 15 years down the line, if you are still around. I write as someone who lived in Asia for the best part of 30 years and have followed China closely since the late 70s. Mark my words - and those of Tom Tugendhat.

An eskimo?

Telit Comms is in the process of being bought 'on the cheap' by foreign buyers and it's a sad reflection of the bargain basement take-outs where progressive British companies are concerned. I sincerely hope that everyone invested here can see the huge future potential for ANGLE as a dynamic, disruptive force for good. Or put another way, I hope you, like me, would do your utmost to fight-off all unwanted opportunistic suitors who might try it on early in the game.